Acta Crystallographica, Section C: Crystal Structure Communications p. 1364 - 1365 (1999)
Update date:2022-08-11
Topics:
Ghosh, Sutapa
Uckun, Fatih M.
The title compound, C11H8Br2N2O2 (LFM-A13), is the first reported BTK-specific tyrosine kinase inhibitor and the first antileukemic agent targeting BTK (Bruton's tyrosine kinase). The crystal structur
View MoreChengda Pharmaceuticals Co., Ltd.
Contact:+86-573-84601188
Address:hengshan Road 5# in Jiashan, zhejiang
SHANGHAI RORY FINE CHEMICALS CO.,LTD
Contact:0086-21-50702305/50343389
Address:Pudong Avenue 3040 building 2 room 103/50343389
shanghai jinshan pharmaceutical Co.,Ltd
Contact:021-57363011,13681638167
Address:No. 7966 Tingfeng Road,Jinshan,Shanghai,China
website:http://www.angchenchem.com
Contact:+86-510-88302099 82327577
Address:Rm. 404/405, Floor 4th, No. 983 FengXiang Road, Wuxi, China
ZHONGBEI NORTHLAND BIO-CHEM INDUSTRY CO.,LTD
Contact:+86-452-6055586
Address:5F, C Liandalijing Bulding,No 259 Xinjiang Road, Jianhua District
Doi:10.1016/0045-6535(94)90356-5
(1994)Doi:10.1016/S0040-4039(01)01335-1
(2001)Doi:10.1002/ejic.201400001
(2014)Doi:10.1039/c9tc00326f
(2019)Doi:10.1246/cl.2001.1194
(2001)Doi:10.1016/S0040-4039(00)76654-8
(1994)